HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet's disease

Tissue Antigens

Volumn 54, Issue 3, 1999, Pages 264-272

  Verity, D H ^a,d   Wallace, G R ^a   Vaughan, R W ^a   Kondeatis, E ^a   Madanat, W ^b   Zureikat, H ^b   Fayyad, F ^b   Marr, J E ^e   Kanawati, C A ^c   Stanford, M R ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b JORDAN HOSPITAL   (Jordan)

^c St John Ophthalmic Hospital   (Israel)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Behcet's disease; HLA; Ocular; TNF polymorphisms

Indexed keywords

HLA B ANTIGEN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BEHCET SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-B ANTIGENS; HUMANS; JORDAN; MALE; MIDDLE AGED; MIDDLE EAST; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RISK FACTORS; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032883868     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540307.x     Document Type: Article

References (28)

1. Palmer HE, Zaman AG, Edelsten CE, Stanford MR, Graham EM. Systemic morbidity in patients with isolated idiopathic retinal vasculitis. Lancet 1995: 346: 505-6.
2. Park KD, Bang D, Lee ES, Lee SH, Lee S. Clinical study on death in Behçet's disease. J Korean Med Sci 1993: 8: 241-5.
3. Feigenbaum A. Description of Behçet's Syndrome in the Hippocratic Third Book of Endemic Diseases, Br J Ophthalmol 1956: 40: 355-7.
4. Behçet R Über rezidiverende, apthöse durch ein Virus verursachte Geschwüre am Mund, am Auge und an der Genitalen. Dermatol Wochenschr 1937: 105: 1152-7.
5. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990: 335: 1078-80.
6. Roger RS. Recurrent aphthous stomatitis in the diagnosis of Behçet's disease. Yonsei Med J 1997: 38: 370-9.
7. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behçet's disease: Immunological aspects. Yonsei Med J 1997: 38: 350-8.
8. Mizuki N, Ohno S. Immunogenetic studies of Behçet's disease. Rev Rheum 1996: 63: 520-7.
9. Sans L, Gonzalez-Escribano MF, de Pablo R, Nunez-Roldan A, Kreisler M, Vilches C. HLA-Cw*1602: a new susceptibility marker of Behçet's disease in southern Spain. Tissue Antigens 1998: 51: 111-4.
10. Mizuki N, Inoko H, Sugimura K et al. RFLP analysis in the TNF β gene and susceptibility to alloreactive NK cells in Behçet's disease. Invest Ophthalmol Vis Sci 1992: 33: 3084-90.
11. Koumantaki Y, Stavropoulos C, Spyropoulou M et al. HLA-B*5101 in Greek patients with Behçet's disease. Hum Immunol 1998: 59: 250-5.
12. Monos DS, Kamoun M. Udalova IA et al. Genetic polymorphism of the human tumour necrosis factor region in insulin dependent diabetes mellitus. Hum Immunol 1995: 44: 70-9.
13. Fodil N, Laloux L, Wanner V et al. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics 1996: 44: 351-7.
14. Bouma G. Xia B, Crusius BA et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996: 103: 391-6.
15. Huizinga TWJ, Westendorp RGJ, Bollen EL et al. TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997: 72: 149-53.
16. Pociot F, Briant L, Jongeneel CV et al. Association of tumour necrosis factor and class II MHC alleles with the secretion of TNF α and TNF β by human mononuclear cells: a possible link to insulin dependent diabetes mellitus. Eur J Immunol 1993: 23: 224-31.
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO. Effects of a polymorphism in the human tumour necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997: 94: 3195-9.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
19. Bunce M, O'Neill CM, Barnado MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, BRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 46: 355-67.
20. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992: 39: 225-35.
21. Bettinotti MP. Hartung K, Deicher h et al. Polymorphism of the tumour necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993: 37: 449-54.
22. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human Tumour Necrosis Factor alpha (TNF α) gene detectable by NCo 1 restriction of PCR product. Hum Mol Gen 1993: 1:353.
23. Alpsoy E, Yilmaz E, Coskun M, Savas M, Yegin O. HLA antigens and linkage disequilibrium patterns in Turkish Behçet's disease patients. J Dermatol 1997: 25: 158-62.
24. Gonzalez-Escribano MF, Rodriguez MR, Walter K, Sanchez-Roman J, Garcia-Lozano JR, Nunez Roldan A. Association of HLA-B51 subtypes and Behçet's disease in Spain. Tissue Antigens 1998: 51:78-80.
25. Gao X, Lester S, Boettcher B, McCluskey J. Diversity of HLA genes in populations of Australia and the Pacific. In: Charron D, ed. Genetic Diversity of HLA. Functional and Medical Implications. Paris: EDK, 1997: 298-305.
26. Boyer G, Templin D, Bowler A et al. Class 1 HLA antigens in spondyloarthropathy: Observations in Alaskan Eskimo patients and controls. J Rheumatol 1997: 24: 500-6.
27. Cabrera M, Shaw AM, Sharples C et al. Polymorphism in tumour necrosis factor genes associated with mucocutaneous Leishmaniasis. J Exp Med 1995: 182: 1259-64.
28. Mege J-L, Dilsen N, Sanguedolce V et al. Overproduction of monocyte derived TNF α, Interleukin (IL) 6, IL 8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993: 20: 1544-9.